Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

Classical paraneoplastic encephalitis syndromes with 'onconeural' antibodies directed to intracellular antigens, and the recently described paraneoplastic or non-paraneoplastic encephalitides and antibodies against both neural surface antigens (voltage-gated potassium channel-complexes, N-methyl-d-aspartate receptors) and intracellular antigens (glutamic acid decarboxylase-65), constitute an increasingly recognized group of immune-mediated brain diseases. Evidence for specific immune mechanisms, however, is scarce. Here, we report qualitative and quantitative immunopathology in brain tissue (biopsy or autopsy material) of 17 cases with encephalitis and antibodies to either intracellular (Hu, Ma2, glutamic acid decarboxylase) or surface antigenic targets (voltage-gated potassium channel-complex or N-methyl-d-aspartate receptors). We hypothesized that the encephalitides with antibodies against intracellular antigens (intracellular antigen-onconeural and intracellular antigen-glutamic acid decarboxylase groups) would show neurodegeneration mediated by T cell cytotoxicity and the encephalitides with antibodies against surface antigens would be antibody-mediated and would show less T cell involvement. We found a higher CD8/CD3 ratio and more frequent appositions of granzyme-B(+) cytotoxic T cells to neurons, with associated neuronal loss, in the intracellular antigen-onconeural group (anti-Hu and anti-Ma2 cases) compared to the patients with surface antigens (anti-N-methyl-d-aspartate receptors and anti-voltage-gated potassium channel complex cases). One of the glutamic acid decarboxylase antibody encephalitis cases (intracellular antigen-glutamic acid decarboxylase group) showed multiple appositions of GrB-positive T cells to neurons. Generally, however, the glutamic acid decarboxylase antibody cases showed less intense inflammation and also had relatively low CD8/CD3 ratios compared with the intracellular antigen-onconeural cases. Conversely, we found complement C9neo deposition on neurons associated with acute neuronal cell death in the surface antigen group only, specifically in the voltage-gated potassium channel-complex antibody patients. N-methyl-d-aspartate receptors-antibody cases showed no evidence of antibody and complement-mediated tissue injury and were distinguished from all other encephalitides by the absence of clear neuronal pathology and a low density of inflammatory cells. Although tissue samples varied in location and in the stage of disease, our findings strongly support a central role for T cell-mediated neuronal cytotoxicity in encephalitides with antibodies against intracellular antigens. In voltage-gated potassium channel-complex encephalitis, a subset of the surface antigen antibody encephalitides, an antibody- and complement-mediated immune response appears to be responsible for neuronal loss and cerebral atrophy; the apparent absence of these mechanisms in N-methyl-d-aspartate receptors antibody encephalitis is intriguing and requires further study.

[1]  R. Balice-Gordon,et al.  Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome , 2011, Neurology.

[2]  P. Convers,et al.  Brain immunohistopathological study in a patient with anti‐NMDAR encephalitis , 2011, European journal of neurology.

[3]  J. Dalmau,et al.  GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders , 2011, Neurology.

[4]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[5]  J. Delrieu,et al.  [Autoimmune channelopathies]. , 2011, La Revue de medecine interne.

[6]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.

[7]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[8]  J. Dalmau,et al.  Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study , 2010, Journal of Neurology.

[9]  D. Kullmann,et al.  N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes , 2010, Brain : a journal of neurology.

[10]  Xiaoyu Peng,et al.  Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis , 2010, The Journal of Neuroscience.

[11]  H. Urbach,et al.  Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis , 2010, Annals of neurology.

[12]  A. Vincent,et al.  The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins , 2010, Current opinion in neurology.

[13]  G. Martino,et al.  Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies , 2010, Journal of the Neurological Sciences.

[14]  D. Friedman,et al.  Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.

[15]  J. Dalmau,et al.  Antibodies and neuronal autoimmune disorders of the CNS , 2010, Journal of Neurology.

[16]  M. Rosenfeld,et al.  Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma , 2009, Acta Neuropathologica.

[17]  C. Good,et al.  HISTOPATHOLOGY OF VGKC ANTIBODY–ASSOCIATED LIMBIC ENCEPHALITIS , 2009, Neurology.

[18]  A. Becker,et al.  CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. , 2009, Brain : a journal of neurology.

[19]  R. Kalb,et al.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location , 2009, Annals of neurology.

[20]  C. Elger,et al.  Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. , 2009, Archives of neurology.

[21]  E. Cho,et al.  Immunoglobulins and complement in postmortem multiple sclerosis tissue , 2009, Annals of neurology.

[22]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[23]  M. Rosenfeld,et al.  Paraneoplastic syndromes of the CNS , 2008, The Lancet Neurology.

[24]  D. Murman,et al.  An autopsy case of limbic encephalitis with voltage‐gated potassium channel antibodies , 2007, European journal of neurology.

[25]  C. Elger,et al.  Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy , 2007, Neurology.

[26]  J. Dalmau,et al.  Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment , 2007, The neurologist.

[27]  C. Elger,et al.  Astrocytes are a specific immunological target in Rasmussen's encephalitis , 2007, Annals of neurology.

[28]  N. Karandreas,et al.  Bilateral drop foot due to thoracic disc herniation , 2007, European journal of neurology.

[29]  J. Winer,et al.  Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. , 2006, Age and ageing.

[30]  K. Digre,et al.  Early pathologic findings and long-term improvement in anti-Ma2–associated encephalitis , 2006, Neurology.

[31]  J. Honnorat,et al.  Management of paraneoplastic neurological syndromes: report of an EFNS Task Force , 2006, European journal of neurology.

[32]  H. Urbach,et al.  VGKC-Antikörper-assoziierte limbische Enzephalitis , 2005, Der Nervenarzt.

[33]  H. Wieser,et al.  Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis , 2004 .

[34]  B. Boeve,et al.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody , 2004, Neurology.

[35]  M. Rossor,et al.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. , 2004, Brain : a journal of neurology.

[36]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[37]  J. Warren,et al.  Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies , 2002, Journal of Clinical Neuroscience.

[38]  D. Hafler,et al.  Amendment history : Corrigendum ( June 2002 ) GAD 65-reactive T cells are activated in patients with autoimmune type 1 a diabetes , 2018 .

[39]  C. Elger,et al.  Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis , 2002, Annals of neurology.

[40]  A. Saiz,et al.  Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis , 2002, Acta Neuropathologica.

[41]  C. Solaro High-dose intravenous immune globulin for stiff-person syndrome. , 2002, The New England journal of medicine.

[42]  G. Escaramís,et al.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. , 2001, Brain : a journal of neurology.

[43]  G. M. Halmágyi,et al.  Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody , 2001, Journal of neurology, neurosurgery, and psychiatry.

[44]  J. Palace,et al.  Pathogenic autoantibodies to neuronal proteins in neurological disorders , 1999, Journal of Neuroimmunology.

[45]  P. De Camilli,et al.  Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma , 1999, Journal of neurology, neurosurgery, and psychiatry.

[46]  P. van Endert,et al.  Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes , 1995, The Journal of experimental medicine.

[47]  Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells. , 1994, Virology.

[48]  J. Dalmau,et al.  Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti‐Hu‐associated paraneoplastic encephalomyelitis , 1994, Neurology.

[49]  H. Ploegh,et al.  HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.

[50]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.